Predicting Post‐Mortem α‐Synuclein Pathology by the Combined Presence of Probable <scp>REM sleep behavior disorder</scp> and Hyposmia

PRBD, diagnosed without sleep study confirmation, combined with a reduced olfactory performance is highly specific for predicting post-mortem presence of LTS. The combination of both measures may provide a cost-effective means of predicting LTS in a broader community.

Authors

Institutions

Publication Details

Journal
Movement Disorders Clinical Practice
Published
2024-11-05
DOI
https://doi.org/10.1002/mdc3.14244
Citations
7
Primary Topic
Parkinson's Disease Mechanisms and Treatments
Type
article
Field-Weighted Citation Impact
2.58

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Predicting Post‐Mortem α‐Synuclein Pathology by the Combined Presence of Probable REM sleep behavior disorder and Hyposmia

Alireza Atri, Charles H. Adler, Cécilia Tremblay, Geidy E. Serrano et al.
7 citations
Movement Disorders Clinical Practice
Parkinson's Disease Mechanisms and Treatments
2.58
article

Predicting Post‐Mortem α‐Synuclein Pathology by the Combined Presence of Probable REM sleep behavior disorder and Hyposmia

Alireza Atri, Charles H. Adler, Cécilia Tremblay, Geidy E. Serrano, David Shprecher, Joyce Lee‐Iannotti, Shyamal H. Mehta, Christine M. Belden, Holly A. Shill, Thomas G. Beach, Parichita Choudhury, Erika Driver‐Dunckley
article en
7 citations

Abstract

PRBD, diagnosed without sleep study confirmation, combined with a reduced olfactory performance is highly specific for predicting post-mortem presence of LTS. The combination of both measures may provide a cost-effective means of predicting LTS in a broader community.

Movement Disorders Clinical PracticeVol. 12(2)
Barrow Neurological Institute (US), University of Arizona (US), Mayo Clinic in Arizona (US), Banner Sun Health Research Institute (US)
Foundation for the National Institutes of Health, Michael J. Fox Foundation for Parkinson's Research, Biogen, Arizona Department of Health Services, Barrow Neurological Foundation, Demensförbundet, Jazz Pharmaceuticals, Eisai, Arizona Biomedical Research Commission, National Institutes of Health, Canadian Institutes of Health Research, Fonds de Recherche du Québec - Santé, National Institute on Aging, National Institute of Neurological Disorders and Stroke
Good health and well-being
Openalex Percentile: Top 9%
Parkinson's Disease Mechanisms and Treatments
2.58
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.